Susceptibility Testing of the Polymyxins: Where Are We Now?-Reference-Cited by-同舟云学术

Susceptibility Testing of the Polymyxins: Where Are We Now?

Published:2014-10-20 Issue:1 Volume:35 Page:22-27
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Humphries Romney M.¹²

Affiliation:

1. Department of Pathology and Laboratory Medicine; University of California; Los Angeles California

2. Clinical Microbiology; UCLA Health System; Los Angeles California

Publisher

Wiley

Subject

Pharmacology (medical)

Reference29 articles.

1. Polymyxins revisited;Landman;Clin Microbiol Rev,2008

2. ISO Clinical laboratory testing and in vitro diagnostic test systems - Susceptibility testing of infectious agents and evaluation of performance of antimicrobial susceptibility test devices. Part 1: Refrence method for testing the in vitro activity of antimicrobial agents against rapidly growing aerobic bacteria involved in infecitous diseases Geneva, Switzerland ISO 2006

3. Variability of polymyxin B major components in commercial formulations;He;Int J Antimicrob Agents,2010

4. In vitro potency of various polymyxin B components;Tam;Antimicrob Agents Chemother,2011

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Colistin, the last resort antibiotic: challenges in the implementation of its routine susceptibility testing;Microbiologia Medica;2024-05-28

2. Colistin Susceptibility Testing by Colistin Broth Disk Elution MIC Method among Carbapenem-resistant Gram-negative Blood Culture Clinical Isolates in a Tertiary Care Setting, East Delhi, India;Ethiopian Journal of Health Sciences;2023-09-21

3. Prevalence of Antibiotic-Resistant Pathogenic Bacteria and Level of Antibiotic Residues in Hospital Effluents in Selangor, Malaysia: Protocol for a Cross-sectional Study;JMIR Research Protocols;2023-05-29

4. Geographical variation in antimicrobial use and multiresistant pathogens in Brazilian intensive care units: a nationwide study;The Journal of Infection in Developing Countries;2023-04-30

5. Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?;Expert Review of Anti-infective Therapy;2023-03-08